Stride Analyst Ratings
Barrington Research Maintains Outperform on Stride, Maintains $90 Price Target
Barrington Maintains Stride(LRN.US) With Buy Rating, Maintains Target Price $90
Citi Downgrades Stride to Neutral Amid Heightened Uncertainty
Citi Maintains Stride(LRN.US) With Hold Rating, Maintains Target Price $90
Stride Analyst Ratings
Citi Downgrades Stride(LRN.US) to Hold Rating, Raises Target Price to $90
BMO Capital Maintains Outperform on Stride, Raises Price Target to $82
Stride Inc: Robust GE Sector Performance and Promising Enrollment Trends Justify Buy Rating
Stride Analyst Ratings
Stride Analyst Ratings
Barrington Maintains Stride(LRN.US) With Buy Rating, Raises Target Price to $85
Barrington Research Adjusts Stride's Price Target to $85 From $75, Keeps Outperform Rating
Stride Analyst Ratings
BMO Capital Maintains Outperform on Stride, Raises Price Target to $73
Barrington Research: Maintaining the Stride (LRN.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $75.00 to $75.00.
Barrington Research Maintains Outperform on Stride, Maintains $75 Price Target
Stride Analyst Ratings
Morgan Stanley Raises Price Target on Stride to $70 From $65, Cites 'Solid Quarter,' Keeps Equalweight Rating
Barrington Research: Maintaining the Stride (LRN.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $75.00 to $75.00.